Hoffman Robert E. — SEC insider filings

SEC reporting owner CIK 1166288. 20 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2020-09-17 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
TuHURA Biosciences, Inc./NV (HURA)Director91 leg · 55,000 sh · $25,795—9
Esperion Therapeutics, Inc. (ESPR)Director4——7
CytoDyn Inc. (CYDY)Chief Executive Officer3——3
FibroBiologics, Inc. (FBLG)Director3——3
Kura Oncology, Inc. (KURA)Director1——1

Insider filings — Hoffman Robert E.

FiledFormIssuerReported transactionsSource
2026-10-204CytoDyn Inc. (CYDY)Grant/award (A): 2,500,000 (derivative) @ $0EDGAR
2026-07-134Esperion Therapeutics, Inc. (ESPR)Disposition to issuer (D): 85,153 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 7,040 (derivative)EDGAR
2026-06-234FibroBiologics, Inc. (FBLG)Grant/award (A): 30,803 (derivative) @ $0EDGAR
2026-06-014Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 79,873 @ $0EDGAR
2026-03-244CytoDyn Inc. (CYDY)Grant/award (A): 4,874,691 (derivative) @ $0EDGAR
2026-02-174TuHURA Biosciences, Inc./NV (HURA)Grant/award (A): 156,240 (derivative) @ $0EDGAR
2025-06-124FibroBiologics, Inc. (FBLG)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2025-06-024Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 5,280 @ $0 · Grant/award (A): 7,040 (derivative) @ $0EDGAR
2025-05-224CytoDyn Inc. (CYDY)Grant/award (A): 1,000,000 (derivative) @ $0EDGAR
2025-04-024Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-01-064TuHURA Biosciences, Inc./NV (HURA)Grant/award (A): 51,275 (derivative) @ $0EDGAR
2024-08-274FibroBiologics, Inc. (FBLG)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-09-014Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 23,142 (derivative) @ $0EDGAR
2023-06-024Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 59,800 @ $0EDGAR
2022-08-034Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 400,145 @ $0 · Grant/award (A): 1,200,634 (derivative) @ $0EDGAR
2022-02-174Kintara Therapeutics, Inc. (KTRA)Purchase (P): 55,000 @ $0.47EDGAR
2021-11-104Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 3,519,170 (derivative) @ $0EDGAR
2021-09-224Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-234Kura Oncology, Inc. (KURA)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2020-09-174Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 120,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1166288 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs